The Health Sector in Transition: Evolution or Revolution?
- Starts: 6:00 pm on Monday, April 25, 2011
- Ends: 8:00 pm on Monday, April 25, 2011
Pressures have been building in the health sector for some time, particularly around issues of cost and quality. However, the basic structure of the sector has remained remarkably constant, even as technology has continued to evolve. Are we finally at an inflection point where these forces will create much more rapid change? What is that change likely to be? What are the dangers and what are the opportunities across the health sector?
Registration: Space is limited so register early. If you have any questions about the event or registration, feel free to email Ceri Gerrish at firstname.lastname@example.org
Parking: Available at the Warren Towers at 700 Commonwealth Ave for $6. Please request a spot(s) at the time of registration.
Cost: There is no cost for the event other than parking. If you wish to contribute to the Health Sector Management Program or to the Spring Event in the future, a table will be set up at the event.
More information about the speakers:
Dr. Gary Gottlieb is the President and CEO of Partners HealthCare. Prior to Partners and since 2002, he was the President of Brigham and Women’s Hospital. Gary received his MBA from the Wharton School of Business Administration and his MD from The Albany Medical College of Union University. The link below is connected to a video of Dr. Gottlieb outlining Partners vision for the future: http://www.partners.org/newnoteworthy/StrategicInitiative.html
Partners HealthCare - Partners HealthCare was founded in 1994 by Brigham and Women's Hospital and Massachusetts General Hospital. Partners is an integrated health care system that offers patients a continuum of coordinated high-quality care. The system includes primary care and specialty physicians, community hospitals, the two founding academic medical centers, specialty facilities, community health centers, and other health-related entities.
James Roosevelt Jr. – Mr. Roosevelt joined Tufts Health Plan in 1999 as senior vice president and general counsel and held that position until June 2005, when he became president and CEO. Before joining Tufts Health Plan, Mr. Roosevelt was the associate commissioner for Retirement Policy for the Social Security Administration in Washington, D.C. He has also served as chief legal counsel for the Massachusetts Democratic Party. Mr. Roosevelt received his J.D. from Harvard Law School and his A.B. with honors in government from Harvard College.
Tufts Health Plan - Founded in 1979 as a not-for-profit health maintenance organization (HMO), Tufts Health Plan today offers a full array of health care coverage options to individuals and through employer groups. With a tagline that reads, "No one does more to keep you healthy," the organization offers its members a variety of innovative tools to engage them in managing their health. This initiative is resulting in high quality care while providing a sound way to control costs.
Mara Aspinall - Mara Aspinall is Chief Executive Officer of On-Q-ity, Inc, an innovative diagnostics company. Previously, Mara was President of Genzyme Genetics, and prior to that was the President of Genzyme Pharmaceuticals. She is an active member of the Federal Secretary of Health and Human Services' Advisory Commission on Genetics, Health and Society and is a Director of the Personalized Medicine Coalition. Mara earned her MBA from Harvard Business School and her undergraduate degree in International relations from Tufts University.
On-Q-ity Inc. – Oncology + Quality + Clarity. On-Q-ity is an innovative diagnostic company dedicated to improving the treatment of individual cancer patients through real time, non-invasive monitoring to better target therapy and lower costs. On-Q-ity enables precise personalized therapeutic decisions to be made through use of their circulating tumor cell (CTC) technology which enables the capture, enumeration, and molecular characterization of CTCs in the bloodstream. These advances enable better decision-making across multiple cancers: improving the quality of life for patients and ultimately increasing survival.